• 1
    Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: The role of flow cytometry versus cytology. Blood 2005;105:496502.
  • 2
    Quijano S, Lopez A, Sancho JM, Panizo C, Deben G, Castilla C, Garcia-Vela JA, Salar A, Alonso-Vence N, Gonzalez-Barca E et al. Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: Improved sensitivity of flow cytometry. J Clin Oncol 2009;27:14621469.
  • 3
    Benevolo G, Stacchini A, Spina M, Ferreri AJM, Arras M, Bellio L, Botto B, Bulian P, Cantonetti M, Depaoli L et al. Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination. Blood 2012;120:32223228.
  • 4
    de Graaf MT, de Jongste AHC, Kraan J, Boonstra JG, Sillevis Smitt PAE, Gratama JW. Flow cytometric characterization of cerebrospinal fluid cells. Cytometry Part B 2011; 80B:271281.
  • 5
    Ahluwalia MS, Wallace PK, Peereboom DM. Flow cytometry as a diagnostic tool in. lymphomatous or leukemic meningitis: Ready for prime time? Cancer 2012;118:17471753.
  • 6
    Wood B. 9-Color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med 2006;130:680690.
  • 7
    Stacchini A, Aliberti S, Demurtas A, Benevolo G, Godio L. Ten antibodies, six colors, twelve parameters: A multiparameter flow cytometric approach to evaluate leptomeningeal disease in B-cell non-Hodgkin's lymphomas. Cytometry Part B 2012;82B:139144.
  • 8
    Preffer F, Lanza F. Issue highlights—May 2012. Cytometry Part B 2012;82B:vvi.
  • 9
    Nowakowski GS, Call TG, Morice WG, Kurtin PJ, Cook RJ, Zent CZ. Clinical significance of monoclonal B cells in cerebrospinal fluid. Cytometry Part B 2005;63B:2327.
  • 10
    DiGiuseppe JA, Fuller SG, Borowitz MJ. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: Potential usefulness in minimal residual disease detection. Cytometry Part B 2009;76B:150155.
  • 11
    DiGiuseppe JA, Cardinali J. Improved compensation of the fluorochrome AmCyan using cellular controls. Cytometry Part B 2011;80B:191194.
  • 12
    Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sayn J, Sommer N, Hartung HP, Hemmer B. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005;128:16671676.
  • 13
    Qin Y, Duquette P, Zhang Y, Olek M, Da R-R, Richardson J, Antel JP, Talbot P, Cashman NR, Tourtellotte WW et al. Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab Invest 2003;83:10811088.
  • 14
    Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Öhman S, Racke MK, Sharief M, Sindic CJM et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: A consensus statement. Arch Neurol 2005;62:865870.
  • 15
    Kuenz B, Lutterotti A, Ehling R, Gneiss C, Haemmerle M, Rainer C, Deisenhammer F, Schocke M, Berger T, Reindl M. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS ONE 2008;3:e2559.
  • 16
    Kussick SJ, Kalnoski M, Braziel RM, Wood BL. Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. Am J Clin Pathol 2004;121:464472.
  • 17
    Marti G, Abbasi F, Raveche E, Rawstron AC, Ghia P, Aurran T, Caporaso N, Shim YK, Vogt RF. Overview of monoclonal B-cell lymphocytosis. Br J Haematol 2007;139:701708.
  • 18
    Attygalle AD, Liu H, Shirali S, Diss TC, Loddenkemper C, Stein H, Dogan A, Du M-Q, Isaacson PG. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: A reactive condition of childhood showing immunoglobulin lambda light chain restriction. Blood 2004;104:33433348.